Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × Thalidomide × Clear all

NCT00004635 2018-05-22

Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

Phase 3 Completed

159 enrolled 9 charts

Neoplasms, Prostatic Neoplasms